Login
$RDN
$37.19 +$0.00 (0.0%) After hours

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Sep 30, 2026
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Assets
Investments (Notes 6 and 7)
Available for sale-at fair value (amortized cost of $6,805,853 and $4,550,954)
Trading-at fair value (amortized cost of $38,068 and $70,050)
Equity securities-at fair value (cost of $29,508 and $45,619)
Residential mortgage loans held for sale-at fair value (Note 7)
Other invested assets—at fair value
Other long-term invested assets-at fair value
Short-term investments-at fair value (includes $90,447 and $62,212 of reinvested cash collateral held under securities lending agreements)
Total investments
Cash
Restricted cash
Accrued investment income
Accounts and notes receivable
Premiums and other receivables
Reinsurance recoverables (includes $33,614 and $1,788 for paid losses)
Deferred policy acquisition costs
Property and equipment, net
Deferred policy acquisition costs and VOBA
Goodwill and other acquired intangible assets (Note 3)
Prepaid federal income taxes (Note 10)
Other assets (Note 9)
Securitized residential mortgage loans held for investment at fair value
Other VIE assets
Assets held for sale (Note 18)
Total assets
Liabilities and stockholders’ equity
Liabilities
Reserve for losses and LAE (Note 11)
Unearned premiums
Senior notes (Note 12)
Other borrowings (Note 12)
Reinsurance funds withheld
Short-term borrowings (Note 12)
Long-term borrowings (Note 12)
Net deferred tax liability
Other liabilities (Note 9)
Securitized nonrecourse debt-at fair value
Other VIE liabilities
Liabilities held for sale (Note 18)
Total liabilities
Stockholders’ equity
Common stock ($0.001 par value; 485,000 shares authorized; 2026: 151,923 and 129,945 shares issued and outstanding, respectively; 2025: 156,913 and 135,498 shares issued and outstanding, respectively)
Treasury stock, at cost (2026: 21,978 shares; 2025: 21,415 shares)
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss) (Note 15)
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support